"Somos una organización dedicada a la conducción de estudios de investigación clínica en diferentes áreas terapéuticas. Ofreciendo servicio de laboratorio clínico privado."

During the past decade, Medical Care & Research SA de CV conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Care & Research SA de CV" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "H. Lundbeck A/S" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Care & Research SA de CV" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Medical Care & Research SA de CV" are "Crohn Disease" (2 trials), "Schizophrenia" (2 trials), "Arthritis, Psoriatic" (1 trials), "Axial Spondyloarthritis" (1 trials) and "Borderline Personality Disorder" (1 trials). Many other conditions were trialed in "Medical Care & Research SA de CV" in a lesser frequency.

Most popular intervention types in "Medical Care & Research SA de CV" are "Drug" (20 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Etrolizumab" (2 trials), "Guselkumab" (2 trials), "Ixekizumab" (2 trials) and "Tirzepatide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medical Care & Research SA de CV" are 19 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Care & Research SA de CV". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Medical Care & Research SA de CV, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Care & Research SA de CV, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".